China
Medical device market intelligence for China. Regulatory changes, competitor moves, and procurement trends.
Country table last refreshed: Aug 9, 2026 (may lag). 7-day count above is live-recomputed (table had 341).
Last 7 days
Pharmosa Biopharm's Inhaled Drug L606 Wins China Approval to Launch Global Phase 3 Trial for Pulmonary Hypertension - finance.biggo.com
Biogen (BIIB) Wins China Approval For At Home Weekly Alzheimer’s Treatment - simplywall.st
China NMPA Accelerates Market Access For Imported Medicines - insights.citeline.com
China approves third medical device standard for brain-computer interfaces - medicalbuyer.co.in
IceCure Secures China NMPA Approval for ProSense Cryoablation System - finance.yahoo.com
IceCure Medical (ICCM) secures China nod for tumor-freezing cancer tool - Stock Titan
China approves a tumor-freezing system from IceCure - Stock Titan
IceCure Medical Receives Regulatory Approval to Market ProSense® in China - PR Newswire